Skip to content

EBITDA at other companies

Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
$52.51M+1,514%
Mobileye Global Inc. logo
Mobileye Global Inc.MBLY
-$3.88B-3,815%
Oric Pharmaceuticals, Inc. logo
Oric Pharmaceuticals, Inc.ORIC
-$39.35M-21.4%
MeiraGTx Holdings plc logo
MeiraGTx Holdings plcMGTX
-$37.81M+1.8%
Intel logo
IntelINTC
Johnson & Johnson logo
Johnson & JohnsonJNJ

Other financials

Income statement

See full
Revenue$179.0K-50.6%
Gross profit$131.0K-56.3%
Operating income-$6.9M-16.2%
Net income-$4.2M+11.6%
EPS (diluted)-$0.08+57.9%

Balance sheet

See full
Cash & equivalents$30.5M-19.6%
Total debt$21.9M+995%
Total equity$75.4M-6.4%
Total assets$92.0M-14.9%

Cash flow

See full
Operating cash flow-$7.3M-128%
CapEx$6.0K
Free cash flow-$7.3M-128%

Valuation

See full
Market cap$170.56M+189%
P/S174×+93.5×

Profitability

See full
Gross margin71.9%
Operating margin-3,717.2%+1,952pp
Net margin-2,117.2%-517pp
FCF margin-2,064.1%

Returns & leverage

See full
Return on equity-26.6%-0.8pp
Debt / equity0.3×+0.2×
Current ratio3.2×-0.7×

Where this comes from

Calculated from Rafael Holdings, Inc.’s reported figures.

$6.9Mebit+
$48.0KDepreciation Depletion & Amortization
=-$6.82M

The official record: Rafael Holdings, Inc.’s 10-Q, filed June 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Rafael Holdings, Inc.'s ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Rafael Holdings, Inc.'s EBITDA?
Rafael Holdings, Inc. (RFL) reported EBITDA of -$6.82M in Q1 2026.
How has Rafael Holdings, Inc.'s EBITDA changed year-over-year?
Rafael Holdings, Inc.'s EBITDA decreased by 16.6% year-over-year, from -$5.85M to -$6.82M.
What is the long-term trend for Rafael Holdings, Inc.'s EBITDA?
Over 4 years (2021 to 2025), Rafael Holdings, Inc.'s EBITDA has grown at a 1.9% compound annual growth rate (CAGR), from -$26.77M to -$28.87M.
What does EBITDA mean?
Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.